Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$2.5B |
| 2 |
Apple
AAPL
|
+$1.68B |
| 3 |
Tesla
TSLA
|
+$951M |
| 4 |
Johnson & Johnson
JNJ
|
+$750M |
| 5 |
UnitedHealth
UNH
|
+$703M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CTXS
Citrix Systems Inc
CTXS
|
+$913M |
| 2 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$257M |
| 3 |
NVIDIA
NVDA
|
+$225M |
| 4 |
Vertiv
VRT
|
+$164M |
| 5 |
JPMorgan Chase
JPM
|
+$161M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.48% |
| 2 | Healthcare | 7.36% |
| 3 | Financials | 6.5% |
| 4 | Consumer Discretionary | 5.35% |
| 5 | Industrials | 3.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1201
CALL
Verizon
VZ
$196B
| $10M | ﹤0.01% |
253,800
+4,800
| +2% | +$181K |
|
1202
Annaly Capital Management
NLY
$17.4B
| $9.96M | ﹤0.01% |
472,418
-308,413
| -39% | -$6.07M |
|
1203
Webster Financial
WBS
$12.8B
| $9.95M | ﹤0.01% |
210,247
+85,174
| +68% | +$4.27M |
|
1204
TransUnion
TRU
$15.3B
| $9.93M | ﹤0.01% |
175,065
+52,921
| +43% | +$3.1M |
|
1205
Lazard
LAZ
$4.31B
| $9.91M | ﹤0.01% |
285,874
+272,455
| +2,030% | +$9.69M |
|
1206
Robert Half
RHI
$4.37B
| $9.9M | ﹤0.01% |
134,112
-958
| -0.7% | -$73.1K |
|
1207
Pebblebrook Hotel Trust
PEB
$2.05B
| $9.89M | ﹤0.01% |
738,772
+20,885
| +3% | +$319K |
|
|
AZPN
1208
CALL
DELISTED
Aspen Technology Inc
AZPN
| $9.86M | ﹤0.01% |
+48,000
| New | +$11.2M |
|
1209
PUT
Chipotle Mexican Grill
CMG
$41.5B
| $9.85M | ﹤0.01% |
+355,000
| New | +$10.6M |
|
1210
Futu Holdings
FUTU
$15.3B
| $9.83M | ﹤0.01% |
241,712
+51,440
| +27% | +$2.51M |
|
1211
CALL
DraftKings
DKNG
$11.9B
| $9.81M | ﹤0.01% |
+861,500
| New | +$12M |
|
|
JOYY
1212
JOYY Inc
JOYY
$3.75B
| $9.81M | ﹤0.01% |
310,398
+177,427
| +133% | +$5.13M |
|
1213
Xtrackers Harvest CSI 300 China A-Shares ETF
ASHR
$1.6B
| $9.79M | ﹤0.01% |
349,500
+74,504
| +27% | +$2.03M |
|
1214
CALL
3M
MMM
$94.3B
| $9.79M | ﹤0.01% |
97,594
+38,751
| +66% | +$3.95M |
|
1215
CALL
Roblox
RBLX
$27B
| $9.78M | ﹤0.01% |
+343,700
| New | +$12.1M |
|
1216
Kymera Therapeutics
KYMR
$8.94B
| $9.75M | ﹤0.01% |
390,650
+37,656
| +11% | +$1M |
|
1217
PUT
Alnylam Pharmaceuticals
ALNY
$29.3B
| $9.74M | ﹤0.01% |
+41,000
| New | +$8.75M |
|
1218
PUT
ARK Innovation ETF
ARKK
$6.31B
| $9.72M | ﹤0.01% |
+311,200
| New | +$11.1M |
|
|
APTV.PRA
1219
DELISTED
Aptiv PLC 5.50% Series A Mandatory Convertible Preferred Shares
APTV.PRA
| $9.68M | ﹤0.01% |
90,228
+25,772
| +40% | +$2.84M |
|
1220
CALL
Chegg
CHGG
$102M
| $9.65M | ﹤0.01% |
382,000
+132,000
| +53% | +$3.35M |
|
1221
Essential Utilities
WTRG
$11.4B
| $9.63M | ﹤0.01% |
201,744
+32,524
| +19% | +$1.47M |
|
1222
CALL
Dick's Sporting Goods
DKS
$18.7B
| $9.62M | ﹤0.01% |
+80,000
| New | +$9.01M |
|
1223
Interactive Brokers
IBKR
$39.8B
| $9.59M | ﹤0.01% |
530,112
-38,800
| -7% | -$725K |
|
1224
DoorDash
DASH
$93.7B
| $9.58M | ﹤0.01% |
196,135
-87,640
| -31% | -$4.55M |
|
1225
PUT
Vertex Pharmaceuticals
VRTX
$126B
| $9.53M | ﹤0.01% |
33,000
| – | – |
|
Similar funds
Barclays's Q4 2022 Portfolio in Review
As of Q4 2022, Barclays held 5,646 positions worth $223B, up 144% from $91.6B the previous quarter. Its ten largest holdings account for 41% of the portfolio.
Barclays deployed $128B of net new capital in Q4 2022, opening 797 new positions and adding to 2,634 existing holdings. Its largest new stake was Seadrill: 1,546,558 shares worth $50.5M.
By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Horizon Therapeutics Public Limited Company Ordinary Shares, an estimated $257M trimmed.
- Barclays's largest Q4 2022 buy was Seadrill: 1,546,558 shares worth $50.5M.
- Barclays added most to Microsoft in Q4 2022, an estimated $2.5B increase.
- Barclays's biggest Q4 2022 reduction was Horizon Therapeutics Public Limited Company Ordinary Shares, cutting an estimated $257M.
- Barclays fully exited Citrix Systems Inc in Q4 2022, selling an estimated $913M.
- Barclays's ten largest holdings make up 41% of its $223B portfolio in Q4 2022.
- Barclays opened 797 new positions and closed 385 in Q4 2022.
- Barclays's portfolio value rose 144% quarter-over-quarter to $223B.
Based on Barclays's 13F filing for Q4 2022, filed 13 Feb 2023.